Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated

Clinical trial NCT06908993 · RECRUITING

Trial details

NCT number: NCT06908993
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Non Small Cell Lung Cancer MET Exon 14 Mutation

Start date: 2025-12-09
Primary completion: 2028-03-15
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.